The Transcatheter strategy for severe mitral regurgitation requiring percutaneous ventricular assist device support study

Transcatheter versus conservative strategies for severe mitral regurgitation requiring Impella support - Treatment strategies with Impella for MR

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000057768

Enrollment

100

Registered

2025-05-03

Start date

2020-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Isolated severe MR complicated by either drug-refractory heart failure or cardiogenic shock requiring Impella support

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with severe MR complicated by drug-refractory heart failure or cardiogenic shock requiring Impella support

Exclusion criteria

Exclusion criteria: Patients who required therapeutic interventions other than for the mitral valve

Design outcomes

Primary

Measure	Time frame
The primary outcome was in-hospital mortality.	—

Secondary

Measure	Time frame
Secondary outcomes were in-hospital events, including cardiac death, stroke, cardiac tamponade, acute kidney injury, sepsis, severe bleeding, limb ischemia, and ventricular tachycardia or fibrillation.	—

Countries

Japan

Contacts

Public ContactTsuyoshi Isawa

Sendai Kousei Hospital Cardiology Department

isa_tsuyo@yahoo.co.jp022-728-8000

Outcome results